Search Results for “” – Page 34 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Clinical outcomes

598 Publications found

The impact of blood culture identification by MALDI-TOF MS on the antimicrobial management of pediatric patients.

b

Diagnostic microbiology and infectious disease

November 1, 2018

p MALDI-TOF MS For Microorganism Identification

c Change patient management Clinical outcomes Observational Operational efficiencies
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome.

b

Journal of the American Heart Association

October 16, 2018

p Cardiovascular Disease

c Clinical outcomes RCT
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.

b

Clinical cancer research : an official journal of the American Association for Cancer Research

October 15, 2018

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.

b

Pregnancy hypertension

October 1, 2018

p Preeclampsia

c Change patient management Clinical outcomes Highlighted Observational
ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.

b

Pediatric diabetes

October 1, 2018

p Diabetes

c Clinical outcomes Guideline
High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

b

Lancet (London, England)

September 15, 2018

p Cardiovascular Disease

c Clinical outcomes RCT
HbA and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.

b

Diabetes care

September 1, 2018

p Diabetes

c Change patient management Clinical outcomes RCT
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial.

b

The Lancet. Respiratory medicine

September 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Procedural Pain during Insertion of a Continuous Glucose Monitoring Device in Preterm Infants.

b

The Journal of pediatrics

September 1, 2018

p Diabetes

c Clinical outcomes RCT
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

b

Journal of Crohn's & colitis

August 29, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational Operational efficiencies